02162 KEYMED BIO-B
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 3.30X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 10.9% | Net Margin | N/A |
Total Debt/Equity | 30.4% | Return on Equity | N/A |
Price/Book | 8.34X | Return on Assets | N/A |
(HKD 78.500) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -547.96 | -396.08 | -345.46 | -4,754.57 | -971.49 |
---|---|---|---|---|---|
Net Profit Growth (%) | -38.3 | -14.7 | +92.7 | -389.4 | -418.8 |
Earnings Per Share (HKD) | -2.092 | -1.515 | -1.323 | -29.559 | -14.479 |
Earnings Per Share Growth (%) | -38.0 | -14.5 | +95.5 | -104.2 | +99.9 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 9.408 | 11.767 | 13.388 | 15.963 | N/A |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 498.752 | 54.682 | +812.1 | 327.124 |
Operating Result | -75.098 | -328.826 | -77.2 | 50.242 |
Associates | -0.566 | -1.698 | -66.7 | -2.097 |
Profit Before Taxation | -75.664 | -330.524 | -77.1 | 48.145 |
Taxation | 3.135 | 6.079 | -48.4 | 0 |
Profit /( Loss) After Taxation | -78.799 | -336.603 | -76.6 | 48.145 |
Minority Interests | 0.044 | 0.142 | -69.0 | 1.178 |
Net Profit | -78.843 | -336.745 | -76.6 | 46.967 |
Earnings Per Share () | -0.3268 | -1.3837 | -76.4 | 0.1940 |
Announcement Date | 2025-08-26 | 2024-08-27 | NA | 2023-08-24 |
* Annualised
Last Update Time: 2025-09-08 21:40:25